Q4 2024 Earnings Call Transcript March 13, 2025 aTyr Pharma, Inc. beats earnings expectations. Reported EPS is $-0.18, expectations were $-0.23. Operator: Good afternoon, ladies and gentlemen, and ...

Market OverviewThe Lung In Vitro Model Market has been experiencing significant growth, driven by advancements in ...

The latest research report published by Vantage Market Research, titled "An Increase in Demand and Opportunities for the ...

The Utah Department of Environmental Quality is not spending hundreds of millions of federal dollars, not because those funds ...

The "Immunotherapy in Oncology Patent Landscape Report and Forecast 2024-2032" report has been added to ...

Idiopathic pulmonary fibrosis is a progressive and life-threatening lung disease but there are ASX companies bringing hope to ...

The Fight for Air Climb in Oakbrook Terrace raised nearly $200,000 for the American Lung Association, with several suburban ...

The ideas and opinions expressed in this Data Supplement do not necessarily reflect those of the American Society of Clinical Oncology (ASCO). The mention of any product, service, or therapy in this ...

Provides Efficient Interaction with Consolidated AI ResultsPALO ALTO, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Fovia Ai, ...

How tribal leaders, commercial fisherman and a few small environmental groups won an uphill campaign against dams.

Lung cancer remains one of the leading causes of cancer-related mortality, with lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC ...

Lung cancer remains one of the leading causes of cancer-related mortality, with lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) representing the most prevalent subtypes of non-small ...